Methotrexate Resistance in Relation to Treatment Outcome in Childhood Acute Lymphoblastic Leukemia

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-015-0158-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Transient Encephalopathy Following High-Dose Methotrexate Treatment in Childhood Acute Lymphoblastic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1998English

Treatment Outcome in Infant Acute Lymphoblastic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2000English

Germline Genetic Variations in Methotrexate Candidate Genes Are Associated With Pharmacokinetics, Toxicity, and Outcome in Childhood Acute Lymphoblastic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2013English

Childhood Acute Lymphoblastic Leukemia

Oncologist
Cancer ResearchMedicineOncology
1997English

Infants With Acute Lymphoblastic Leukemia: No Evidence for High Methotrexate Resistance

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2002English

Epigenetic Priming in Childhood Acute Lymphoblastic Leukemia

Frontiers in Cell and Developmental Biology
Developmental BiologyCell Biology
2019English

Nutritional Considerations in Childhood Acute Lymphoblastic Leukemia

Cancer and Oncology Research
2020English

Mathematical Model to Predict Methotrexate Elimination in Children With Acute Lymphoblastic Leukemia

Romanian Review of Laboratory Medicine
2014English

Editorial: Prognostic Factors in Childhood Acute Lymphoblastic Leukemia

Pediatric Hematology and Oncology
Child HealthOncologyPediatricsPerinatologyHematology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy